SOPHiA GENETICS S.A. (SOPH) Stock Overview
Explore SOPHiA GENETICS S.A.’s financial performance, market position, analyst ratings, and future outlook.
SOPHiA GENETICS S.A. (SOPH)
Key Financials
Key Financials
Market Cap
639.3M
P/E Ratio
-6.58
EPS (TTM)
$-1.11
ROE
-1.37%
SOPH Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of SOPHiA GENETICS S.A. (NASDAQ: SOPH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, SOPHiA GENETICS S.A.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SOPH on the NASDAQ shows an RSI of 69.62, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $6.50 for the NASDAQ listing.
Key metrics behind SOPHiA GENETICS S.A.'s NASDAQ-traded stock include a P/E ratio of -6.58 and a market capitalization of 639.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SOPH on the NASDAQ.